Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis
Authors:
- Vilma dos Santos Trindade VianaVVVilma dos Santos Trindade Viana
- Maurício Levy-NetoMLMaurício Levy-Neto
- Fernando Henrique Carlos de SouzaFSFernando Henrique Carlos de Souza
- Samuel Katsuyuki ShinjoSSSamuel Katsuyuki Shinjo
Open Access
Abstract
To analyze the prevalence of myositis-specific and myositis-associated autoantibodies and their clinical correlations in a large series of patients with dermatomyositis/polymyositis. This cross-sectional study enrolled 127 dermatomyositis cases and 95 polymyositis cases. The disease-related autoantibody profiles were determined using a commercially available blood testing kit. The prevalence of myositis-specific autoantibodies in all 222 patients was 34.4%, whereas myositis-associated autoantibodies were found in 41.4% of the patients. The most frequently found autoantibody was anti-Ro-52 (36.9%), followed by anti-Jo-1 (18.9%), anti-Mi-2 (8.1%), anti-Ku (4.1%), anti-SRP (3.2%), anti-PL-7 (3.2%), anti-PL-12 (2.7%), anti-PM/Scl75 (2.7%), and anti-PM/Scl100 (2.7%). The distributions of these autoantibodies were comparable between polymyositis and dermatomyositis, except for a higher prevalence of anti-Jo-1 in polymyositis. Anti-Mi-2 was more prevalent in dermatomyositis. Notably, in the multivariate analysis, anti-Mi-2 and anti-Ro-52 were associated with photosensitivity and pulmonary disorders, respectively, in dermatomyositis. Anti-Jo-1 was significantly correlated with pulmonary disorders in polymyositis. Moreover, anti-Ro-52 was associated with anti-Jo-1 in both diseases. No significant correlation was observed between the remaining autoantibodies and the clinical and/or laboratory findings. Our data are consistent with those from other published studies involving other populations, although certain findings warrant consideration. Anti-Ro-52 and anti-Jo-1 were strongly associated with one another. Anti-Ro-52 was correlated with pulmonary disorders in dermatomyositis, whereas anti-Jo-1 was correlated with pulmonary alterations in polymyositis.Keywords
This publication has 38 references indexed in Scilit:
- Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assayRheumatology, 2010
- Inflammatory Myopathies: Evaluation and ManagementSeminars in Neurology, 2008
- Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significanceCurrent Opinion in Rheumatology, 2007
- Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomesArthritis Research & Therapy, 2007
- Myositis‐specific and myositis‐associated antibodies in a series of eighty‐eight mediterranean patients with idiopathic inflammatory myopathyArthritis Care & Research, 2006
- Clinical implications of autoantibody screening in patients with autoimmune myositisAutoimmunity, 2006
- In patients with antisynthetase syndrome the occurrence of anti-Ro/SSA antibodies causes a more severe interstitial lung diseaseAutoimmunity, 2006
- Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase.Journal of Clinical Investigation, 1993
- A New Approach to the Classification of Idiopathic Inflammatory MyopathyMedicine, 1991
- Prevalence of Ro (SS‐A) antibodies in patients with polymyositisArthritis & Rheumatism, 1987